President Donald Trump tweeted another attack on Amazon, his fifth in a week, this time focusing his criticism on The Washington Post, which is owned by the online retailer’s CEO, Jeff Bezos.
“The Fake News Washington Post, Amazon’s ‘chief lobbyist,’ has another (of many) phony headlines,” the president tweeted, criticizing the newspaper’s coverage of the US trade standoff with China.
Trump’s tweet was aimed at an article in the Thursday, April 5, morning edition of the Post, which said that the president “showed no sign” of backing down during trade tensions with China.
Trump’s slam on The Post came on the heels of his own spokeswoman’s admission Wednesday that the stock market’s recent roller-coaster ride, which was widely attributed to the president’s budding China trade war, could give investors “short-term pain” before Wall Street rebounds.
“The president is worried that we have countries that have been taking advantage of us for decades and that he’s not going to allow that to happen anymore,” Press Secretary Sarah Sanders told reporters. “We may have a little bit of short-term pain but we’re certainly going to have long-term success.”
Beijing shoved back hard Wednesday after the administration published a 43-page collection of Chinese goods it planned to hit with new tariffs, retaliating with a list of similar duties on US imports including soybeans, planes, cars, beef and chemicals.
Full Content: Daily Mail & 10 News
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas